SAMe Phytic Acid Complexes for Natural Stability

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for producing stable salts of S-adenosyl-L-methionine (SAMe) methyl donor compounds involve the use of xenobiotic counter-ions, which are costly and not of natural origin, leading to instability and degradation issues.

Innovation Solution

The production of salts or complexes of methyl donors like SAMe with phytic acid or phosphorylated inositol, utilizing natural counter-ions that provide biological activity and stability through a simple and cost-effective process, eliminating the need for xenobiotic substances.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Stability of the object's composition

If xenobiotic counter-ions are used to produce stable salts of SAMe, then stability is improved, but the product becomes costly and loses natural origin

Engineering Contradiction:
ImprovestabilityVSAvoidcost
Core Design Contradiction:
Stability of the object's compositionVSEase of manufacture

Solution Approach 1:

The patent changes the chemical parameter of the counter-ion from synthetic xenobiotic substances to natural substances (phytic acid and its derivatives). This parameter change maintains stability while eliminating the need for costly synthetic additives, as phytic acid forms stable complexes with SAMe through natural chelation mechanisms.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent achieves homogeneity by using all-natural components (SAMe and phytic acid) that are compatible and naturally occurring. This eliminates the need for multiple different synthetic counter-ions and simplifies the product composition to naturally compatible substances, reducing manufacturing complexity and cost.

Inventive Principle:
Principle #33Homogeneity

2Stability of the object's composition

If xenobiotic counter-ions are used to produce stable salts of SAMe, then stability is improved, but the product is not of natural origin

Engineering Contradiction:
ImprovestabilityVSAvoidxenobiotic components
Core Design Contradiction:
Stability of the object's compositionVSObject-generated harmful factors

Solution Approach 1:

The patent extracts and removes xenobiotic counter-ions from the SAMe salt formulation, replacing them with natural phytic acid. This extraction eliminates harmful synthetic components while preserving the essential stabilizing function through natural chelation between phytic acid and SAMe.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent replaces expensive, unstable synthetic counter-ions with a cheap, naturally occurring substance (phytic acid) that provides equivalent or superior stability. Phytic acid is abundant in nature and can be obtained through simple extraction from plant sources, eliminating the need for costly synthetic chemistry.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

3Ease of manufacture

If simple and cost-effective process is used with natural counter-ions, then ease of manufacture is improved, but stability may be compromised

Engineering Contradiction:
Improveease of manufactureVSAvoidstability
Core Design Contradiction:
Ease of manufactureVSStability of the object's composition

Solution Approach 1:

The patent enables the system to be self-stabilizing through the natural chelation properties of phytic acid. The phytic acid-SAMe complex forms spontaneously through natural chemical affinity without requiring complex stabilization mechanisms, expensive additives, or sophisticated manufacturing controls, achieving both simplicity and stability simultaneously.

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The resulting compounds exhibit enhanced stability and biological activity, combining the benefits of methyl donors with the antioxidant and chelating properties of phytic acid, without using xenobiotic components, and can be formulated into stable nutraceutical or pharmaceutical products.

Implementation Method 1

The present invention concerns the production of salts or chelates of methyl donors, such as S-adenosyl-L-methionine or SAMe and betaine or trimethylglycine, with phytic acid or with phosphorylated inositol, with the formation of totally natural stable compounds

Methodology Applied
Scientific EffectChelation:

Implementation Method 2

The resulting compounds exhibit enhanced stability and biological activity, combining the benefits of methyl donors with the antioxidant and chelating properties of phytic acid

Methodology Applied
Scientific EffectOxidation: Oxidation

Data Source

PatentUS8293254B2Salts or complexes of methyl donors with phytic acid or its derivatives and method for the synthesis thereof
Publication Date: 2012.10.23 DE LUCA MARIA
  • US8293254B2 patent drawing
  • US8293254B2 patent drawing
  • US8293254B2 patent drawing

AI summary

The invention concerns the production of salts or chelates of methyl donors, in particular S-adenosyl-L-methionine or SAMe and betaine or N,N,N-trimethylglycine, with phytic acid or with phosphorylate inositol, possibly partially salified with metal cations, with the formation of stable, totally natural, compounds having a biological activity typical of the starting methyl donors and also combined with, and enhanced by, the biological activity typical of phytic acid or of inositol.The invention also concerns nutraceutical, pharmaceutical, dietary, phytopharmaceutical or veterinary compositions comrising one or more salts or complexes of methyl donors with phytic acid or its derivatives and the method for the synthesis thereof.